Predictive Oncology Inc. (POAI)
USD 1.07
(0.0%)
USD 1.07
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -13.98 Million USD | 61.38% |
| 2022 | -36.2 Million USD | -84.2% |
| 2021 | -19.65 Million USD | 47.86% |
| 2020 | -37.7 Million USD | -36.82% |
| 2019 | -27.55 Million USD | -173.2% |
| 2018 | -10.08 Million USD | -30.21% |
| 2017 | -7.74 Million USD | -18.7% |
| 2016 | -6.52 Million USD | -36.23% |
| 2015 | -4.79 Million USD | 29.9% |
| 2014 | -6.83 Million USD | 27.35% |
| 2013 | -9.4 Million USD | -26.73% |
| 2012 | -7.42 Million USD | -65.42% |
| 2011 | -4.48 Million USD | -231.7% |
| 2010 | -1.35 Million USD | 53.23% |
| 2009 | -2.89 Million USD | -64.09% |
| 2008 | -1.76 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -3.18 Million USD | 24.59% |
| 2024 Q1 | -4.21 Million USD | -21.39% |
| 2023 Q1 | -4.25 Million USD | 80.87% |
| 2023 Q4 | -3.47 Million USD | -9.86% |
| 2023 Q3 | -3.16 Million USD | 19.37% |
| 2023 Q2 | -3.92 Million USD | 7.84% |
| 2023 FY | -13.98 Million USD | 61.38% |
| 2022 Q3 | -3.98 Million USD | 77.19% |
| 2022 Q2 | -17.48 Million USD | -425.59% |
| 2022 FY | -36.2 Million USD | -84.2% |
| 2022 Q1 | -3.32 Million USD | 57.1% |
| 2022 Q4 | -22.25 Million USD | -458.04% |
| 2021 Q3 | -5.43 Million USD | -111.27% |
| 2021 FY | -19.65 Million USD | 47.86% |
| 2021 Q4 | -7.75 Million USD | -42.63% |
| 2021 Q2 | -2.57 Million USD | 33.81% |
| 2021 Q1 | -3.88 Million USD | 66.1% |
| 2020 Q2 | -3.57 Million USD | 21.02% |
| 2020 Q3 | -6.3 Million USD | -76.32% |
| 2020 FY | -37.7 Million USD | -36.82% |
| 2020 Q1 | -4.52 Million USD | 66.58% |
| 2020 Q4 | -11.46 Million USD | -81.84% |
| 2019 FY | -27.55 Million USD | -173.2% |
| 2019 Q1 | -3.29 Million USD | 4.44% |
| 2019 Q2 | 1.44 Million USD | 143.87% |
| 2019 Q3 | -4 Million USD | -377.46% |
| 2019 Q4 | -13.55 Million USD | -238.13% |
| 2018 FY | -10.08 Million USD | -30.21% |
| 2018 Q2 | -2.37 Million USD | -34.85% |
| 2018 Q1 | -1.76 Million USD | 38.65% |
| 2018 Q4 | -3.44 Million USD | -37.47% |
| 2018 Q3 | -2.5 Million USD | -5.62% |
| 2017 Q4 | -2.86 Million USD | -189.19% |
| 2017 FY | -7.74 Million USD | -18.7% |
| 2017 Q1 | -1.34 Million USD | -83.12% |
| 2017 Q3 | -992.09 Thousand USD | 61.0% |
| 2017 Q2 | -2.54 Million USD | -89.56% |
| 2016 Q4 | -732.77 Thousand USD | 30.58% |
| 2016 FY | -6.52 Million USD | -36.23% |
| 2016 Q3 | -1.05 Million USD | 58.79% |
| 2016 Q2 | -2.56 Million USD | -17.69% |
| 2016 Q1 | -2.17 Million USD | 3.83% |
| 2015 Q3 | -1.11 Million USD | 5.81% |
| 2015 Q2 | -1.18 Million USD | -424.96% |
| 2015 Q1 | -225.79 Thousand USD | 90.45% |
| 2015 FY | -4.79 Million USD | 29.9% |
| 2015 Q4 | -2.26 Million USD | -102.71% |
| 2014 FY | -6.83 Million USD | 27.35% |
| 2014 Q4 | -2.36 Million USD | -112.1% |
| 2014 Q1 | -1.61 Million USD | 24.94% |
| 2014 Q2 | -1.73 Million USD | -7.36% |
| 2014 Q3 | -1.11 Million USD | 35.76% |
| 2013 Q3 | -3.97 Million USD | -238.14% |
| 2013 Q1 | -2.1 Million USD | -22.37% |
| 2013 Q4 | -2.15 Million USD | 45.8% |
| 2013 Q2 | -1.17 Million USD | 44.06% |
| 2013 FY | -9.4 Million USD | -26.73% |
| 2012 Q3 | -2.85 Million USD | -33.71% |
| 2012 Q4 | -1.71 Million USD | 39.86% |
| 2012 FY | -7.42 Million USD | -65.42% |
| 2012 Q2 | -2.13 Million USD | -199.39% |
| 2012 Q1 | -713.36 Thousand USD | 75.96% |
| 2011 Q1 | -477.43 Thousand USD | -20.4% |
| 2011 Q3 | -654.11 Thousand USD | -68.85% |
| 2011 Q4 | -2.96 Million USD | -353.74% |
| 2011 FY | -4.48 Million USD | -231.7% |
| 2011 Q2 | -387.38 Thousand USD | 18.86% |
| 2010 FY | -1.35 Million USD | 53.23% |
| 2010 Q3 | -158.11 Thousand USD | -239.54% |
| 2010 Q4 | -396.52 Thousand USD | -150.79% |
| 2010 Q2 | -46.56 Thousand USD | 93.8% |
| 2010 Q1 | -751.5 Thousand USD | -99.45% |
| 2009 Q4 | -376.79 Thousand USD | 51.26% |
| 2009 FY | -2.89 Million USD | -64.09% |
| 2009 Q3 | -773.01 Thousand USD | -4.89% |
| 2009 Q2 | -736.96 Thousand USD | 26.7% |
| 2009 Q1 | -1 Million USD | -24.55% |
| 2008 FY | -1.76 Million USD | 0.0% |
| 2008 Q3 | -447.53 Thousand USD | 0.0% |
| 2008 Q4 | -807.27 Thousand USD | -80.38% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -63.32 Million USD | 77.916% |
| AngioDynamics, Inc. | -184.34 Million USD | 92.414% |
| AtriCure, Inc. | -30.43 Million USD | 54.058% |
| Avinger, Inc. | -18.32 Million USD | 23.668% |
| Azenta, Inc. | -14.25 Million USD | 1.915% |
| BioLife Solutions, Inc. | -66.42 Million USD | 78.948% |
| The Cooper Companies, Inc. | 294.2 Million USD | 104.753% |
| Daxor Corporation | 280.64 Thousand USD | 5082.884% |
| Ekso Bionics Holdings, Inc. | -15.19 Million USD | 7.988% |
| Femasys Inc. | -14.24 Million USD | 1.847% |
| GlucoTrack, Inc. | -7.09 Million USD | -97.041% |
| Harvard Bioscience, Inc. | -3.41 Million USD | -309.487% |
| Hologic, Inc. | 789.5 Million USD | 101.771% |
| ICU Medical, Inc. | -29.65 Million USD | 52.844% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 100.778% |
| KORU Medical Systems, Inc. | -13.74 Million USD | -1.768% |
| LeMaitre Vascular, Inc. | 30.1 Million USD | 146.451% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -109.861% |
| Innovative Eyewear, Inc. | -6.66 Million USD | -109.861% |
| Masimo Corporation | 81.5 Million USD | 117.158% |
| Microbot Medical Inc. | -10.74 Million USD | -30.205% |
| Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | 220.288% |
| Merit Medical Systems, Inc. | 94.41 Million USD | 114.812% |
| Nephros, Inc. | -1.57 Million USD | -787.871% |
| NovoCure Limited | -207.04 Million USD | 93.246% |
| NEXGEL, Inc. | -3.15 Million USD | -342.951% |
| NEXGEL, Inc. | -3.15 Million USD | -342.951% |
| Singular Genomics Systems, Inc. | -94.82 Million USD | 85.252% |
| OraSure Technologies, Inc. | 53.65 Million USD | 126.063% |
| Pro-Dex, Inc. | 2.12 Million USD | 757.45% |
| Pulse Biosciences, Inc. | -42.21 Million USD | 66.87% |
| Precision Optics Corporation, Inc. | -2.95 Million USD | -373.812% |
| QuidelOrtho Corporation | -10.1 Million USD | -38.455% |
| Repligen Corporation | 41.57 Million USD | 133.634% |
| Sanara MedTech Inc. | -4.3 Million USD | -224.967% |
| STAAR Surgical Company | 21.34 Million USD | 165.508% |
| Sharps Technology, Inc. | -9.84 Million USD | -42.09% |
| Utah Medical Products, Inc. | 16.63 Million USD | 184.064% |
| DENTSPLY SIRONA Inc. | -132 Million USD | 89.406% |
| Jin Medical International Ltd. | 2.87 Million USD | 585.853% |